Iovance Biotherapeutics Inc. – Filings and Transcripts

NASDAQ: IOVA
Share price (9/29/26): $14.45
Market cap (9/29/26): $6.545 billion

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 06/30/26 Q2

ended 03/31/26 Q1

ended 12/31/25 FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Registration of securities for employees

Registration of securities for employees

Automatic shelf registration

Registration of securities for employees

Registration of securities for employees

Ownership Filter

Vogt Frederick G

Vogt Frederick G

News Filter

Raises Full Year 2026 Revenue Guidance to $410 to $420 Million

Investor Presentation

Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates

Investor Presentation

Amtagvi® (Lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Preliminary proxy

Additional info about upcoming vote

Definitive proxy

Other Filter

Scanned paper annual report submission

Scanned paper annual report submission

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC